Apyx medical corporation to participate in the jmp securities life sciences conference

Clearwater, fla.--(business wire)--apyx medical corporation (nasdaq:apyx) (the “company”), a maker of medical devices and supplies and the developer of helium plasma technology, marketed and sold as renuvion® in the cosmetic surgery market and j-plasma® in the hospital surgical market, announced today that management will participate in the jmp securities life sciences conference, which is being held virtually from june 16th-17th. management will participate in a fireside chat on wednesday, jun
APYX Ratings Summary
APYX Quant Ranking